New proteomic analyses show that rezpegaldesleukin increases the protein levels of immune-regulating pathways while reducing ...

The American Academy of Dermatology also suggests washing your face and beard daily with a fragrance-free, non-comedogenic ...

AbbVie (NYSE: ABBV) today announced positive results from a new post-hoc analysis from the Measure Up 1 and Measure Up 2 Phase 3 studies. The analysis evaluated the efficacy of upadacitinib (15 mg or ...

Amgen (NASDAQ:AMGN) today announced TEPEZZA® (JAN: Teprotumumab (Genetical Recombination)) has been approved for the treatment of active or high ...

ZORYVE demonstrated consistent efficacy in disease clearance and reduction in itch for individuals with atopic dermatitis (AD) regardless of ...

Delayed diagnosis and treatment of CCCA result in insufficiently aggressive therapy and risks an avoidable consequence, ...

Discover Arcutis Biotherapeutics' groundbreaking patent for a topical treatment targeting alopecia areata, featuring SHR0302 and innovative silicone formulations for effective hair restoration.

Discover Equillium Inc.'s groundbreaking patent for a ?c cytokine antagonist peptide, offering new hope for treating alopecia and immune-mediated hair loss.

Dr. Crystal Aguh, a doctor at Johns Hopkins Medicine, is now using a diabetes medicine named metformin to combat hair loss in ...

When Jordan Emanuel began filming the latest season of Bravo TV’s Summer House: Martha’s Vineyard, she wasn’t sure if she’d ...

Arash Mostaghimi, MD, MPA, MPH, assistant professor of dermatology, director of the inpatient dermatology consult service, and codirector of the Complex Medical Dermatology Fellowship at Brigham & ...

Kate, 42, announced on Sept. 9 that she had completed treatment six months after revealing she had an undisclosed type of cancer.